Market Research Report
Plastic Prefillable Syringes, June 2015
|Published by||Greystone Research Associates||Product code||332038|
Delivery time: 1-2 business days
The trend toward patient self-administration of injectables continues to have a broad influence on the drug delivery sector. While prefillable syringe manufacturers continue to improve and refine their products, from a materials technology standpoint the most dynamic developments are occurring in the refinement of PFS constructed of plastic rather than glass. To date, plastic PFS have made significant inroads in EMS injectables, a segment dominated by Hospira's Ansyr plastic PFS product line. Now, as materials technology continues to advance, market sector participants are targeting mainstream therapeutic drugs.
A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.